Health Lilly’s Retatrutide Shows Dramatic Weight Loss in Phase 3 Obesity Trial May 21, 2026 Groundbreaking Phase 3 Results for Triple Agonist Therapy Eli Lilly announced positive topline results from TRIUMPH-1, a pivotal Phase 3 clinical trial. The study evaluated retatrutide, an investigational triple hormone…